Showing results (1531-1540 of 1,670) with videos related to

Sort By:
Pageof 167
Communications Biology|November 14, 2023
Evaluation of pliable bioresorbable, elastomeric aortic valve prostheses in sheep during 12 months post implantationAnnemijn Vis, Bente J de Kort, Wojciech Szymczyk, et al.
Journal of Cancer Research and Clinical Oncology|February 23, 2017
Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysisAndreas Hochhaus, Franҫois-Xavier Mahon, Philipp le Coutre, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2020
Knowledge-Based Assessment of Focal Dose Escalation Treatment Plans in Prostate CancerMarcel A van Schie, Tomas M Janssen, Dave Eekhout, et al.
European Journal of Haematology|June 2, 2012
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMTArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Leukemia|April 9, 2025
Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final resultsJorge E Cortes, Fabian Lang, Delphine Rea, et al.
Journal of Patient-Reported Outcomes|September 13, 2023
Health-related quality of life of Adolescent and Young Adult Cancer Survivors before and during the COVID-19 pandemic: longitudinal improvements on social functioning and fatigueCarla Vlooswijk, Silvie H M Janssen, Lonneke V van de Poll-Franse, et al.
Applied Health Economics and Health Policy|January 9, 2023
Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUMIrina Pokhilenko, Luca M M Janssen, Aggie T G Paulus, et al.
Annals of Hematology|April 29, 2023
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effectsInge G P Geelen, Stein-Erik Gullaksen, Mette M Ilander, et al.
Paediatric Drugs|September 11, 2023
Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)Alba Rubio-San-Simón, Natasha K A van Eijkelenburg, Raoull Hoogendijk, et al.
Plos Biology|November 10, 2020
NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotypeMahmoud H Elbatreek, Sepideh Sadegh, Elisa Anastasi, et al.
Pageof 167